Authors:
Chiarugi, L
Prisco, D
Antonucci, E
Capanni, M
Fedi, S
Liotta, AA
Margheri, M
Simonetti, I
Gensini, FG
Abbate, R
Citation: L. Chiarugi et al., Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty, ATHEROSCLER, 154(1), 2001, pp. 129-135
Authors:
Prisco, D
Fatini, C
Battaglini, B
Gensini, F
Fedi, S
Falai, M
Chioccioli, M
Gori, AM
Margheri, M
Gensini, GF
Citation: D. Prisco et al., Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients, INT J CL L, 30(4), 2000, pp. 179-185
Authors:
Capanni, M
Antonucci, E
Chiarugi, L
Boddi, V
Abbate, R
Prisco, D
Giglioli, C
Dabizzi, RP
Margheri, M
Simonetti, I
Gensini, GF
Citation: M. Capanni et al., Impairment of early fibrinolytic activation after PTCA: a mechanism for restenosis-related clinical recurrence?, FIBRINOL PR, 13(1), 1999, pp. 8-14
Authors:
Capanni, M
Prisco, D
Antonucci, E
Chiarugi, L
Boddi, V
Abbate, R
Giglioli, C
Dabizzi, RP
Margheri, M
Simonetti, I
Gensini, GF
Citation: M. Capanni et al., The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty, INT J CL L, 29(4), 1999, pp. 145-149
Authors:
Falciani, M
Gori, AM
Giusti, B
Fedi, S
Capanni, M
Simonetti, I
Margheri, M
Prisco, D
Abbate, R
Gensini, GF
Citation: M. Falciani et al., Percutaneous Transluminal Coronary Angioplasty procedure is associated to a decrease in Transforming Growth Factor Beta 1 levels, THROMB HAEM, 82(3), 1999, pp. 1204-1205